01.16.09
Gary W. Thompson has joined bioRASI as vice president of business development. The company has expanded its worldwide operations and is now upgrading its business development functions. Mr. Thompson will lead these global efforts.
"We are extremely pleased to bring a person of Gary's caliber to head our business development functions," said Dr. Boris Reznik, chairman of bioRASI. "Over three decades, Gary has played an integral role in shaping the biotech and pharma industry. In every area he has proved himself a very strong leader; likeable, knowledgeable, and well trusted by the industry. In conjunction with the opening of several new offices around the world, Gary will lead our efforts, providing optimal solutions to our clients' clinical development programs."
Prior to joining the company, Mr. Thompson served as the vice president of business development for Bio Pharma Services as well as the head of business development for Veeda Clinical Research, a CRO in India. Previously, he held leading business development positions with major CROs including BASi, PPD Pharmaco, and Phoenix International Life Sciences.
"We are extremely pleased to bring a person of Gary's caliber to head our business development functions," said Dr. Boris Reznik, chairman of bioRASI. "Over three decades, Gary has played an integral role in shaping the biotech and pharma industry. In every area he has proved himself a very strong leader; likeable, knowledgeable, and well trusted by the industry. In conjunction with the opening of several new offices around the world, Gary will lead our efforts, providing optimal solutions to our clients' clinical development programs."
Prior to joining the company, Mr. Thompson served as the vice president of business development for Bio Pharma Services as well as the head of business development for Veeda Clinical Research, a CRO in India. Previously, he held leading business development positions with major CROs including BASi, PPD Pharmaco, and Phoenix International Life Sciences.
